ReSTORing good vision

Article

The diffractive AcrySof ReSTOR (Alcon) intraocular lens (IOL) can provide stable, high levels of spectacle independence for both near and distance vision.

The diffractive AcrySof ReSTOR (Alcon) intraocular lens (IOL) can provide stable, high levels of spectacle independence for both near and distance vision, according to Rudy Nuijts and colleagues from the Academic Hospital Maastricht, The Netherlands.

A total of 45 eyes of 23 patients who received the ReSTOR SA60D3 IOL were followed in a prospective trial. Patients were assessed preoperatively and six months and three years postoperatively.

No significant changes in uncorrected distance visual acuity (UCDVA) and best corrected distance visual acuity (BCDVA) were noted between the six month and three year time points.

At six months postoperatively, 78% and 83% of patients no longer required spectacles for near and distance vision respectively. At three years 73% and 74% of patients still did not require spectacles for near and distance vision, respectively. Near vision without glasses at six months and three years was 4.0 and 3.7, respectively and 4.3 and 3.8 for distance vision, respectively. Ninety percent of subjects declared themselves to be satisfied with intermediate vision tasks at both time points. Moderate to severe glare was reported by 9.9% and 4.3% at six months and three years and halos were reported by 8.7% and 4.3%, respectively.

Dr Nuijts and his colleagues concluded that the ReSTOR lens achieves excellent near and distance visual results in the majority of patients.

Recent Videos
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Enrico Borrelli, MD, FEBO, speaks at EURETINA
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
© 2024 MJH Life Sciences

All rights reserved.